TrialPanorama/TrialPanorama-database huggingface dataset:
Study 22357572 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22359536 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 22360576 — Predictive Biomarker (PRD): BCL11A mRNA
Genes: BCL11A; CTIP1; EVI9; KIAA1809; ZNF856
Study 22362253 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study 22364114 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22364114 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22364114 — Surrogate Endpoint (SUR): Blood pressure
Study 22367574 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 22367707 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 22367707 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 22368272 — Predictive Biomarker (PRD): CRLF2 mRNA
Genes: CRLF2; CRL2; ILXR; TSLPR
Study 22368272 — Predictive Biomarker (PRD): IKZF1 mRNA
Genes: IKZF1; IK1; IKAROS; LYF1; ZNFN1A1
Study 22368272 — Predictive Biomarker (PRD): P2RY8 mRNA
Genes: P2RY8
Study 22368272 — Pharmacodynamic Biomarker (PDY): Interleukin 7 receptor alpha
Genes: IL7R
Study 22368281 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 22371427 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 22371878 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 22373834 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22374129 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 22374129 — Safety Biomarker (SAF): BDNF
Study 22377126 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 22378848 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 22378848 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 22383693 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 22383795 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 22383795 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study 22383795 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 22383800 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22383800 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 22384093 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22384093 — Predictive Biomarker (PRD): TCF7 mRNA
Genes: TCF7; TCF1
Study 22384093 — Predictive Biomarker (PRD): GZMA mRNA
Genes: GZMA; CTLA3; HFSP
Study 22388712 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study 22388712 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22396313 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 22396517 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 22396585 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 22402037 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 22403000 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 22405335 — Predictive Biomarker (PRD): EHF mRNA
Genes: EHF; ESE3; ESE3B; ESEJ
Study 22405335 — Monitoring Biomarker (MOI): HBV DNA
Study 22415951 — Surrogate Endpoint (SUR): Forced vital capacity
Study 22416063 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 22416102 — Predictive Biomarker (PRD): ATRX mRNA
Genes: ATRX; RAD54L; XH2
Study 22417933 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 22419704 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 22419704 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22419719 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22419878 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 22421192 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study 22421192 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 22421192 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 22421192 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study 22421340 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Interleukin 6 receptor alpha
Genes: IL6R
Study 22421340 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22421340 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22424880 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 22425822 — Predictive Biomarker (PRD): CA1 mRNA
Genes: CA1
Study 22425822 — Predictive Biomarker (PRD): CA3 mRNA
Genes: CA3
Study 22426369 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 22426890 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 22426890 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 22427378 — Predictive Biomarker (PRD): CYBB mRNA
Genes: CYBB; NOX2
Study 22427577 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study 22427678 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22428786 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 22430088 — Predictive Biomarker (PRD): CR2 mRNA
Genes: CR2; C3DR
Study 22431570 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 22431702 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 22436147 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22437560 — Surrogate Endpoint (SUR): Blood pressure
Study 22438225 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 22438229 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 22438229 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 22438256 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 22438931 — Safety Biomarker (SAF): Interleukin 1
Study 22438987 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 22439666 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 22439900 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 22439900 — Surrogate Endpoint (SUR): Blood pressure
Study 22442346 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 22447794 — Predictive Biomarker (PRD): HDGFL2 mRNA
Genes: HDGFL2; HDGF2; HDGFRP2; HRP2; UNQ785/PRO1604
Study 22448814 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 22448921 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 22448921 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 22450529 — Surrogate Endpoint (SUR): Blood pressure
Study 22452895 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 22454801 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 22454801 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22456661 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22457087 — Surrogate Endpoint (SUR): Serum creatinine
Study 22457244 — Surrogate Endpoint (SUR): Blood pressure
Study 22465214 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 22465288 — Surrogate Endpoint (SUR): Blood pressure
Study 22466348 — Surrogate Endpoint (SUR): Blood pressure
Study 22467666 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 22471287 — Predictive Biomarker (PRD): CXCR3 mRNA
Genes: CXCR3; GPR9
Study 22471287 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 22475206 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 22475206 — Surrogate Endpoint (SUR): Total kidney volume
Study 22475206 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 22475563 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 22476856 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 22483418 — Surrogate Endpoint (SUR): Blood pressure
Study 22483418 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22483418 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 22490570 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 22491195 — Predictive Biomarker (PRD): ATXN1 mRNA
Genes: ATXN1; ATX1; SCA1
Study 22491195 — Pharmacodynamic Biomarker (PDY): Ataxin-2
Genes: ATXN2; ATX2; SCA2; TNRC13
Study 22491195 — Pharmacodynamic Biomarker (PDY): Ataxin-3
Genes: ATXN3; ATX3; MJD; MJD1; SCA3
Study 22491731 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 22491731 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 22493293 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 22493293 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 22494861 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 22498112 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 22500948 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22500948 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 22503160 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 22504925 — Surrogate Endpoint (SUR): Hematologic response
Study 22504934 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 22506003 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study 22507624 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22507624 — Predictive Biomarker (PRD): LTA mRNA
Genes: LTA; TNFB; TNFSF1
Study 22508715 — Pharmacodynamic Biomarker (PDY): Amyloid beta peptide (1-40)
Genes: APP; A4; AD1
Study 22508715 — Predictive Biomarker (PRD): PICALM mRNA
Genes: PICALM; CALM
Study 22508715 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22508715 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 22508772 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study 22508812 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 22510871 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 22511402 — Surrogate Endpoint (SUR): Blood pressure
Study 22511402 — Surrogate Endpoint (SUR): Serum creatinine
Study 22511498 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 22512844 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 22516401 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 22516441 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22516441 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22520270 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22520529 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study 22522212 — Predictive Biomarker (PRD): WNT2 mRNA
Genes: WNT2; INT1L1; IRP
Study 22522212 — Predictive Biomarker (PRD): FOXP2 mRNA
Genes: FOXP2; CAGH44; TNRC10
Study 22522212 — Predictive Biomarker (PRD): EN2 mRNA
Genes: EN2
Study 22522617 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 22523363 — Surrogate Endpoint (SUR): Blood pressure
Study 22524974 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 22524974 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study 22528284 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study 22534421 — Surrogate Endpoint (SUR): Blood pressure
Study 22534421 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22537906 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 22537906 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study 22537906 — Predictive Biomarker (PRD): BMP4 mRNA
Genes: BMP4; BMP2B; DVR4
Study 22539091 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 22542159 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): FasL mRNA
Genes: FASLG; APT1LG1; CD95L; FASL; TNFSF6
Study 22542159 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 22542159 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22542159 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 22543737 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22547151 — Predictive Biomarker (PRD): SGSH mRNA
Genes: SGSH; HSS
Study 22547163 — Predictive Biomarker (PRD): AKTIP mRNA
Genes: AKTIP; FTS
Study 22547579 — Surrogate Endpoint (SUR): Blood pressure
Study 22547583 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study 22554401 — Predictive Biomarker (PRD): FAIM mRNA
Genes: FAIM; FAIM1
Study 22554417 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 22555165 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22555974 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22556025 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 22558076 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study 22558101 — Predictive Biomarker (PRD): TUSC2 mRNA
Genes: TUSC2; C3orf11; FUS1; LGCC; PDAP2
Study 22558154 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study 22558154 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 22562290 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22562290 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22562290 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22563743 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22566312 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 22566506 — Predictive Biomarker (PRD): DPYSL5 mRNA
Genes: DPYSL5; CRMP5; ULIP6
Study 22566605 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 22566747 — Surrogate Endpoint (SUR): Blood pressure
Study 22577154 — Predictive Biomarker (PRD): BCL2L10 mRNA
Genes: BCL2L10; BCL-B; BCLB; BOO; DIVA
Study 22580120 — Surrogate Endpoint (SUR): Pathological complete response
Study 22581488 — Surrogate Endpoint (SUR): Blood pressure
Study 22581488 — Surrogate Endpoint (SUR): Serum creatinine
Study 22582313 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22582313 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22582313 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 22583335 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22583335 — Predictive Biomarker (PRD): S100A12 mRNA
Genes: S100A12
Study 22583335 — Safety Biomarker (SAF): Interleukin 1
Study 22590502 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22592608 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 22592608 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22592608 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study 22592608 — Safety Biomarker (SAF): IL-6 and IL-10
Study 22594491 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 22605616 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 22605616 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 22605650 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 22605650 — Predictive Biomarker (PRD): MITF mRNA
Genes: MITF; BHLHE32
Study 22605655 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22605655 — Predictive Biomarker (PRD): IFITM1 mRNA
Genes: IFITM1; CD225; IFI17
Study 22605655 — Predictive Biomarker (PRD): ITGB2 mRNA
Genes: ITGB2; CD18; MFI7
Study 22605655 — Predictive Biomarker (PRD): IL1R2 mRNA
Genes: IL1R2; IL1RB
Study 22605655 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 22607892 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22607892 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22610494 — Surrogate Endpoint (SUR): Blood pressure
Study 22612475 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 22612475 — Surrogate Endpoint (SUR): Serum testosterone
Study 22614885 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22614885 — Monitoring Biomarker (MOI): HBV DNA
Study 22615340 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22624038 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22624038 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22626819 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 22627678 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 22633629 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 22633670 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 22634621 — Predictive Biomarker (PRD): CCR7 mRNA
Genes: CCR7; CMKBR7; EBI1; EVI1
Study 22634621 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study 22634621 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22634621 — Safety Biomarker (SAF): C-C motif chemokine 19
Genes: CCL19; ELC; MIP3B; SCYA19
Study 22634621 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 22634621 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 22639293 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 22639293 — Safety Biomarker (SAF): Cytochrome c
Study 22644887 — Surrogate Endpoint (SUR): Blood pressure
Study 22645182 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 22645182 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 22646832 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study 22647431 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22647431 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22648179 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 22648486 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 22649106 — Predictive Biomarker (PRD): GATA2 mRNA
Genes: GATA2
Study 22649106 — Predictive Biomarker (PRD): CEBPA mRNA
Genes: CEBPA; CEBP
Study 22651703 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study 22651868 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-34a
Genes: MIR34A
Study 22651868 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-210
Genes: MIR210
Study 22652104 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 22652104 — Predictive Biomarker (PRD): Hormone receptor
Study 22655593 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 22659961 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 22659961 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 22661451 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 22661474 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 22661483 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 22664059 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 22673018 — Surrogate Endpoint (SUR): Blood pressure
Study 22674435 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22677240 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study 22681919 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 22682017 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 22682017 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 22684655 — Surrogate Endpoint (SUR): Serum uric acid
Study 22684655 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 22684655 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 22684655 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2